Saturday, January 25, 2020

IIIM Jammu to conduct first ever study of ‘Cannabis’ in India

New Delhi, November 24: Indian Institute of Integrated Medicine, Jammu, in collaboration with Tata Memorial Centre (TMC), Mumbai will conduct a landmark study on cannabis.  At a one-day conference on “Cannabis R&D in India” on Friday, Union Minister Dr Jitendera Singh said the government had granted a license to IIIM Jammu for the cultivation of cannabis for medical research and drug development.

Dr Singh said, Cannabidiol (CBD) has its therapeutic indications in the management of excruciating pain in conditions like Diabetic Neuropathy, cancers, besides its potential indications in children with epilepsy and sickle cell anaemia.

Possibly the first of its kind, the study is to explore the potential clinical benefits of ‘marijuana’— a medicinal plant, which has been surrounded by controversy, owing to its global abuse as a habit-forming substance of addiction.

Three major science administrators in India — The Council of Scientific and Industrial Research, the Indian Council for Medical Research and the Department of Biotechnolgy — are getting together to promote the research in herbal drugs.

“CSIR-IIIM Jammu has been given the responsibility of undertaking this study because the institute specialises in herbal and medicinal plants and has a legacy of undertaking pioneering research in the field ever since the time of its founding father Sir Ram Nath Chopra,” Singh said.

Marijuana (or hemp), more formally parts of the cannabis super-family, is illegal for commercial cultivation though it grows as weed in several parts of the country. Uttarakhand, Jammu and — as of this month Uttar Pradesh — have allowed restricted cultivation of the plant for medical research.

Pointing out that there was a very thin line between the use and abuse of a drug, Singh said that while therapeutic uses of the drug would come to the rescue of needy patients, its misuse would be prevented and regulated through appropriate legislation and law enforcement agencies.

Dr Ram Vishwakarma, Director CSIR-IIIM, Jammu, in his address, said that Cannabis has a historical and cultural linkage in India and is found in abundance in parts of J&K, Uttarakhand and Himachal Pradesh. He profusely thanked Dr Jitendra for facilitating the permission to IIIM Jammu for cultivation and medical research on Cannabis. He informed that after the conclusion of the trial of the drug, the next step would be to explore the feasibility for permission to use it in clinical practice.

The studies into the therapeutic potential of marijuana is part of a larger governmental thrust to making new drugs derived from herbs and plants that find mention in Ayurvedic and other traditional-medicine knowledge systems.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Recent posts

Restoration of Broadband, 2G internet in J&K starting tomorrow

Pallavi Sareen Jammu, Jan 24: The Jammu and Kashmir administration issued orders late Friday instructing the restoration of broadband and 2G internet service in Kashmir...

Shri Mata Vaishno Devi Shrine Board to have Agarbattis from flower waste

Straightline News Network KATRA, Jan 24: Council of Scientific and Industrial Research (CSIR) - Central Institute of Medicinal and Aromatic Plants (CIMAP), Lucknow signed...

J&K suffered due to historical mistakes, economy suffered immensely: Anurag

Straightline News Network JAMMU, Jan 19: Union Minister of State for Finance and Corporate Affairs Anurag Thakur today said that Jammu and Kashmir has...

100 percent implementation of DDUGJY, PMDP in 252 Jammu villages

Straightline News Network DODA, Jan 19: Union Minister of State for Power, New & Renewable Energy, Skill Development and Entrepreneurship, Raj Kumar Singh today...

Rs. 25, 000 crore projects to be completed by year 2021 in J&K

Straightline News Network JAMMU, Jan 19: Central Government is committed on its promise for exemplary transformation on developmental front across Jammu and Kashmir after...